+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hot Flashes Drug"

From
Hot Flashes - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hot Flashes - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hot Flashes - Pipeline Insight, 2024 - Product Thumbnail Image

Hot Flashes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Hot Flashes Drug market is a subset of Sexual and Reproductive Health Drugs, which are used to treat a variety of conditions related to sexual and reproductive health. Hot Flashes Drugs are used to treat menopausal symptoms, such as hot flashes, night sweats, and vaginal dryness. These drugs are typically hormone replacement therapies, such as estrogen and progesterone, or selective serotonin reuptake inhibitors (SSRIs). Hot Flashes Drugs are often prescribed to women who are experiencing menopausal symptoms, as well as those who are at risk of developing them. The Hot Flashes Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, and Eli Lilly. Other companies in the market include Bayer, GlaxoSmithKline, and AstraZeneca. Show Less Read more